A Registry for People With T-cell Lymphoma

Part of paid clinical trials in Duarte, California.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT05978141
Status
Recruiting
Apply to this trial

Conditions

  • Adult T-cell Leukemia/Lymphoma
  • Aggressive NK-cell Leukemia
  • Anaplastic Large Cell Lymphoma, ALK-Positive
  • Anaplastic Large Cell Lymphoma, ALK-negative
  • Angioimmunoblastic T-cell Lymphoma
  • Breast Implant-Associated Anaplastic Large Cell Lymphoma
  • Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form
  • Chronic Lymphoproliferative Disorder of NK Cells
  • Enteropathy-associated T-cell Lymphoma
  • Extranodal NK/T-cell Lymphoma, Nasal Type
  • Follicular T-Cell Lymphoma
  • Hepatosplenic T-cell Lymphoma
  • Hydroa Vacciniforme-Like Lymphoproliferative Disorder
  • Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
  • Intestinal T-Cell Lymphoma, Not Otherwise Specified
  • Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
  • Mycosis Fungoides
  • NK-Cell Lymphoma
  • Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma
  • Primary Cutaneous Anaplastic Large Cell Lymphoma
  • Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma
  • Primary Cutaneous T-cell Lymphoma
  • Sezary Syndrome
  • Subcutaneous Panniculitis-Like T-Cell Lymphoma
  • Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood
  • Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)
  • T-cell Large Granular Lymphocytic Leukemia
  • T-cell Lymphoma
  • T-cell Prolymphocytic Leukemia

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Optional Blood Sample and Nail Sample — OTHER
    Participants may provide optional research blood and nail samples for biobanking and future use

Study Details

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Key Dates

Start date
Jul 27, 2023
Status verified
May 2026
Primary completion
Jul 27, 2030
Completion
Jul 27, 2030

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Participants with T-Cell Lymphoma
    Participants with pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma

Primary Outcome Measure

Number of participants populating the T-cell Lymphoma Master Repository/TCLMR [ Time Frame: 10 years ]

Central Contacts

Locations (26)

FacilityCityStateZIPSite coordinators
City of Hope Cancer Center (Data collection only)DuarteCalifornia91010
Jasmine Zain, MD
626-359-8111
UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)San DiegoCalifornia92103
Aaron Goodman, MD
858-822-6100
University of California San Francisco (Data collection only)San FranciscoCalifornia94143
Weiyun Ai, MD
415-353-2421
Stanford University Medical Center (Data collection only)StanfordCalifornia94305-5408
Michael Khodadoust, MD
650-725-5071
University of Colorado (Data Collection Only)AuroraColorado80045
Bradley Haverkos, MD
212-639-3983
Yale University (Data Collection Only)New HavenConnecticut06511
Francine Foss, MD
203-200-4363
University of Miami (Data Collection Only)MiamiFlorida33136
Jonathan Schatz, MD
305-243-5302
Moffitt Cancer Center (Data Collection Only)TampaFlorida33612
Lubomir Sokol, MD, PhD
888-663-3488
Emory University (Data Collection Only)AtlantaGeorgia30322
Pamela Allen, MD, MSc
404-778-0519
Northwestern Medicine (Data Collection)ChicagoIllinois60611
Jaehyuk Choi, MD, PhD
312-695-8106
Dana Farber Cancer Institute (Data Collection Only)BostonMassachusetts02115
Eric D Jacobsen, MD
877-442-3324
Massachusetts General Hospital (Data Collection Only)BostonMassachusetts02114
Salvia Jain, MD
857-392-4495
Mayo Clinic (Data Collection Only)RochesterMinnesota55905
Nora Bennani, MD
507-284-2511
Washington University (Data Collection Only)St LouisMissouri63110
Neha Mehta-Shah, MD, MSCI
314-747-1171
University of Nebraska (Data collection only)OmahaNebraska68198-7680
Matthew Lunning, DO, FACP
402-559-4000
Memorial Sloan Kettering at Basking Ridge (All protocol activities)Basking RidgeNew Jersey07920
Steven Horwitz, MD
646-608-2680
Memorial Sloan Kettering Monmouth (All protocol activities)MiddletownNew Jersey07748
Steven Horwitz, MD
646-608-2680
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities)CommackNew York11725
Steven Horwitz, MD
646-608-2680
Memorial Sloan Kettering Westchester (All protocol activities)HarrisonNew York10604
Steven Horwitz, MD
646-608-2680
Memorial Sloan Kettering Cancer Center (All Protocol Activities)New YorkNew York10065
Steven Horwitz, MD
646-608-2680
Weill Cornell Medical Center (Data Collection Only)New YorkNew York10021
Jia Ruan, MD, PhD
646-962-2064
Memorial Sloan Kettering Nassau (All protocol activities)UniondaleNew York11553
Steven Horwitz, MD
646-608-2680
Ohio State University (Data Collection Only)ColumbusOhio43210
John Reneau, MD, PhD
614-293-8000
Thomas Jefferson University Hospital (Data collection only)PhiladelphiaPennsylvania19107
Pierluigi Porcu, MD
215-955-8874
University of Pennsylvania (Data Collection Only)PhiladelphiaPennsylvania19104
Stefan Barta, MD, MS, MRCPCUK
(215) 316-5151
MD Anderson Cancer Center (Data Collection Only)HoustonTexas77030
Swami Iyer, MD
713-352-2952

Find similar trials in Duarte, CA

By research site
City of Hope Cancer Center (Data collection only)· Duarte, CAUNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)· San Diego, CAUniversity of California San Francisco (Data collection only)· San Francisco, CAStanford University Medical Center (Data collection only)· Stanford, CAUniversity of Colorado (Data Collection Only)· Aurora, COYale University (Data Collection Only)· New Haven, CT

Related Studies